斯莱克(300382) - 2022 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2022 reached ¥621,032,255, representing a 124.20% increase compared to the same period last year[5] - Net profit attributable to shareholders was ¥110,750,707, a significant increase of 192.56% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥110,639,200, reflecting a 189.27% increase compared to the previous year[5] - Basic earnings per share for the quarter were ¥0.19, up 216.67% from ¥0.06 in the same quarter last year[5] - The company's operating revenue for Q3 2022 reached ¥1,279,795,326.36, a significant increase of 92.15% compared to ¥666,054,267.10 in the same period last year[11] - Net profit for the period was CNY 181,701,747.25, compared to CNY 69,227,499.74 in the previous year, marking an increase of about 162.0%[33] - The total comprehensive income for the period was CNY 184,274,061.07, compared to CNY 67,444,829.23 in the previous year, reflecting an increase of approximately 173.0%[34] Assets and Liabilities - Total assets as of September 30, 2022, amounted to ¥3,878,719,940.68, marking a 44.61% increase from the beginning of the year[5] - The company's total assets increased to CNY 3,878,719,940.68 from CNY 2,682,214,180.38, a growth of about 44.6%[31] - The company's total liabilities increased to CNY 1,446,963,001.27 from CNY 1,340,007,340.64, reflecting a rise of approximately 7.9%[31] - Shareholders' equity attributable to the parent company increased by 76.23% to ¥2,350,630,465.92 compared to the beginning of the year[5] - The total equity attributable to shareholders of the parent company rose to CNY 2,350,630,465.92, up from CNY 1,333,814,622.48, indicating a growth of around 76.2%[31] Cash Flow - Cash flow from operating activities showed a significant decline, with a net outflow of ¥177,073,200, a decrease of 226.52% compared to the previous year[5] - The net cash flow from operating activities was -¥177,073,242.71, a decline of 226.52% compared to ¥139,961,994.68 in the previous year, due to increased cash payments for goods and services[12] - Operating cash flow for the period was -177,073,242.71 CNY, a decrease from 139,961,994.68 CNY in the previous period[35] - Total cash inflow from operating activities was 1,078,834,403.19 CNY, compared to 1,007,565,665.14 CNY in the prior period[35] - Cash outflow from operating activities increased to 1,255,907,645.90 CNY from 867,603,670.46 CNY year-over-year[35] - Net cash flow from investing activities was -640,515,635.94 CNY, worsening from -175,229,649.57 CNY in the previous year[36] - Cash inflow from financing activities was 1,312,796,265.24 CNY, significantly higher than 319,137,119.39 CNY in the prior period[36] - Net cash flow from financing activities improved to 1,029,324,866.04 CNY from -50,943,039.18 CNY year-over-year[36] - The company reported a cash and cash equivalents balance of 514,620,888.70 CNY at the end of the period, up from 329,327,847.20 CNY previously[36] Investments and Acquisitions - The company completed the acquisition of 55% equity in Changzhou Hesheng with a total investment of CNY 91,221,321, which includes a capital contribution of CNY 10,000,000[26] - The goodwill from the acquisition of Changzhou company amounted to ¥27,506,866.93, representing a 78.44% increase from ¥15,415,247.98[11] - The company has approved a total guarantee limit of up to CNY 400,000,000 for inter-company guarantees in 2022[26] - The company provided a guarantee of CNY 180,000,000 for its wholly-owned subsidiary Xi'an Silek Technology Development Co., Ltd. for bank financing[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,206, with the largest shareholder, Kales Co., Ltd., holding 46.75% of the shares[13] - The company issued 46,116,740 new shares to 18 investors on August 25, 2022, as part of a targeted stock issuance[18] - The total amount raised from the issuance was confirmed to be deposited into a dedicated account within one month of the funds being in place[18] - The company’s preferred shareholders include major institutional investors such as UBS AG and China Bank, with significant holdings from the stock issuance[16] - The company’s stock issuance was approved by the China Securities Regulatory Commission on July 20, 2022[17] - The company’s stock issuance was part of a broader strategy to enhance capital and support future growth initiatives[17] - The company’s stock issuance was subject to a six-month transfer restriction from the date of listing[16] Research and Development - Research and development expenses for the quarter were CNY 35,163,232.13, compared to CNY 29,292,129.15 in the previous year, an increase of about 20.1%[33] Other Financial Metrics - Operating costs rose to ¥874,162,615.05, reflecting a 119.37% increase from ¥398,488,756.34, driven by higher sales volume[11] - Operating costs for the quarter were CNY 1,037,676,046.59, up from CNY 560,380,475.94, indicating an increase of approximately 85.0%[32] - The financial expenses decreased dramatically by 97.30% to ¥910,760.01 from ¥33,750,717.53, due to foreign exchange gains[11] - The company reported a decrease in financial expenses to CNY 910,760.01 from CNY 33,750,717.53, a reduction of about 97.3%[33]